Related Experiment Video
Updated: Oct 15, 2025

03:22
Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
565
Post-COVID-19 mucormycosis presenting as chest wall cellulitis with mediastinitis
Navneet Arora1, Ajay Gudipati1, Reetu Kundu2
1Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
The Lancet. Infectious Diseases
|October 31, 2021
Abstract
No abstract available in PubMed .
More Related Videos
Related Concept Videos
Pneumonia III: Complications and Assessment
523
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
523
Flail Chest-II
283
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
283
Pneumonia II: Pathophysiology
947
The pathophysiology of pneumonia involves the following steps:
947
Pneumothorax-II
457
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
457
Pulmonary Tuberculosis III
516
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
516
Pulmonary Tuberculosis II
632
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
632

